Sanofi to Acquire Blueprint Medicines for $9.1B Business By Jack Mulligan Sanofi SA (NASDAQ: SNY) announced on Monday that it has agreed to acquire Blueprint Medicines Corporation (NASDAQ: BPMC) in a…
China’s Growing Influence in the U.S. Biopharma Industry Business By Jack Mulligan A little-known biotech company stunned the industry last spring when Summit Therapeutics announced its experimental cancer drug showed greater effectiveness…
Regeneron Pharmaceuticals: A Promising Future Ahead Business By Lorenzo Sorvani Regeneron Pharmaceuticals (REGN 0.68%) has been making waves in the biotech industry, with a remarkable growth trajectory and a solid…
